July 24, 2017

68Ga-Somatostatin Analog PET-CT Linked to Reduced Costs Reduced costs versus 111In-octreotide scintigraphy for imaging neuroendocrine tumors

For imaging neuroendocrine tumors, 68Ga-somatostatin analog positron emission tomography-computed tomography (PET-CT) is associated with reduced costs compared with 111In-octreotide scintigraphy, according to a study published online July 17 in the Journal of Medical Imaging and Radiation Oncology. {read more here}